Effectiveness of a Khorasan Wheat-Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia.


Journal

Pain medicine (Malden, Mass.)
ISSN: 1526-4637
Titre abrégé: Pain Med
Pays: England
ID NLM: 100894201

Informations de publication

Date de publication:
01 10 2020
Historique:
pubmed: 4 6 2020
medline: 20 5 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

To investigate the effects of a replacement diet with Khorasan wheat products in patients with fibromyalgia, in comparison with a similar replacement diet with control products made from organic semi-whole-grain modern wheat. Randomized, double-blinded crossover trial. Outpatient clinic. Twenty subjects (19 female and one male, mean age = 48.9 ± 12.3 years) with fibromyalgia. Participants were randomly assigned to consume either Khorasan or control wheat products (pasta, bread, crackers, biscuits) for eight weeks and then crossed. Validated self-administered questionnaires were collected from each subject at the beginning and end of each intervention period. A general linear model for repeated measurement, adjusted for potential confounders, showed that the overall score reported from each questionnaire improved after both intervention and control periods, but the effect was more evident after the intervention with Khorasan. In particular, a statistically significant difference in Widespread Pain Index (WPI) + Severity Scale (SS) and Functional Outcome of Sleep Questionnaire (FOSQ) was observed, which decreased significantly by 21.5% and 11.7% respectively, only after the Khorasan period, while no statistically significant variations were reported after the control period. Similarly, FM Impact Questionnaire scores decreased significantly only after the Khorasan period, with a reduction that was significantly different between the intervention and control periods (-22.5% vs -0.3%, P = 0.037). The improvement was even greater in people with higher symptom severity. A dietary intervention with Khorasan wheat products seems to benefit patients with fibromyalgia, especially those with greater symptom severity.

Identifiants

pubmed: 32488245
pii: 5850633
doi: 10.1093/pm/pnaa134
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2366-2372

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Giuditta Pagliai (G)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Unit of Clinical Nutrition, Careggi University Hospital, Florence, Italy.

Barbara Colombini (B)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Monica Dinu (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Unit of Clinical Nutrition, Careggi University Hospital, Florence, Italy.

Anne Whittaker (A)

Department of Agrifood Production and Environmental Sciences, University of Florence, Florence, Italy.

Alberto Masoni (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Giovanna Danza (G)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Amedeo Amedei (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Giovanna Ballerini (G)

Multidisciplinary Center for Pain Therapy, Reference Center for Fibromyalgia, Piero Palagi Hospital, USL Toscana Centro, Florence, Italy.

Stefano Benedettelli (S)

Department of Agrifood Production and Environmental Sciences, University of Florence, Florence, Italy.

Francesco Sofi (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Unit of Clinical Nutrition, Careggi University Hospital, Florence, Italy.
Don Carlo Gnocchi Foundation Italy, Onlus IRCCS, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH